Dermata Therapeutics, Inc. - Common Stock (DRMA)

1.4600
+0.2500 (20.66%)
NASDAQ · Last Trade: Mar 22nd, 7:25 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close1.210
Open1.490
Bid1.300
Ask1.370
Day's Range1.370 - 1.840
52 Week Range1.110 - 23.70
Volume39,595,109
Market Cap1.50M
PE Ratio (TTM)0.0162
EPS (TTM)90.4
Dividend & YieldN/A (N/A)
1 Month Average Volume3,755,476

Chart

About Dermata Therapeutics, Inc. - Common Stock (DRMA)

Dermata Therapeutics Inc is a biotechnology company focused on developing innovative therapeutics for skin diseases and conditions. The company leverages its proprietary technology platform to create treatments that aim to improve patient outcomes in dermatology. Dermata Therapeutics is committed to addressing unmet medical needs and advancing its product candidates through various stages of clinical development. By prioritizing research and development, the company seeks to bring forward effective solutions for skin health and enhance the quality of life for individuals affected by dermatological disorders. Read More

News & Press Releases

What's going on in today's sessionchartmill.com
Via Chartmill · March 20, 2026
Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
Via Chartmill · March 20, 2026
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Via Chartmill · March 20, 2026
Get insights into the top gainers and losers of Thursday's after-hours session.chartmill.com
Via Chartmill · March 19, 2026
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
- Kyra Peckaitis will lead the launch of Dermata's recently announced Tome skincare brand -
Via ACCESS Newswire · March 10, 2026
Dermata Opens a New Chapter with the Release of Tome Skincare
-The oldest new thing in skincare -
Via ACCESS Newswire · March 5, 2026
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Via Chartmill · February 20, 2026
Top movers in Friday's sessionchartmill.com
Via Chartmill · February 20, 2026
Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
Via Chartmill · February 20, 2026
Which stocks are moving before the opening bell on Friday?chartmill.com
Via Chartmill · February 20, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · February 19, 2026
These stocks are moving in today's sessionchartmill.com
Via Chartmill · February 19, 2026
Gapping stocks in Thursday's sessionchartmill.com
Via Chartmill · February 19, 2026
Tuesday's after hours session: top gainers and loserschartmill.com
Via Chartmill · January 27, 2026
Top movers analysis one hour before the close of the markets on 2026-01-26: top gainers and losers in today's session.chartmill.com
Via Chartmill · January 26, 2026
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
This patent grant follows the Company's U.S. issued patent, covering its Spongilla technology combination as a method to topically treat acne
Via ACCESS Newswire · January 20, 2026
In today's session, these stocks are experiencing unusual volume.chartmill.com
Let's explore the current happenings on the US markets on Tuesday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Via Chartmill · December 30, 2025
Tuesday's session: gap up and gap down stockschartmill.com
In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · December 30, 2025
Top movers in Tuesday's pre-market sessionchartmill.com
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.
Via Chartmill · December 30, 2025
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon the exercise in full of warrants
Via ACCESS Newswire · December 29, 2025
These stocks are moving in today's sessionchartmill.com
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · December 26, 2025
Top movers in Friday's sessionchartmill.com
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Via Chartmill · December 26, 2025
Why Did Dermata Therapeutics Stock Surge 22% Pre-Market Today?stocktwits.com
The company has entered into definitive agreements to issue roughly 2.02 million shares of its common stock in a private placement deal.
Via Stocktwits · December 24, 2025
These stocks that are showing activity before the opening bell on Wednesday.chartmill.com
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · December 24, 2025
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon the exercise in full of warrants
Via ACCESS Newswire · December 24, 2025